ライフサイエンスコーパス: initial symptom

1 dness, or a feeling of disequilibrium as the initial symptom.

2 must extend for at least 4 months after the initial symptoms.

3 ware of this entity and be able to recognize initial symptoms.

4 ion, even when applied within a few weeks of initial symptoms.

5 an period of 9 days (range, 2-90 days) after initial symptoms.

6 allenging due to these diseases' nonspecific initial symptoms.

7 atient outcome, but challenging due to vague initial symptoms.

8 adually subsided 6 months after the onset of initial symptoms.

9 al weakness also developed a few weeks after initial symptoms.

10 bodies appearing between days 8 and 14 after initial symptoms.

11 01), and a higher proportion of gait-related initial symptoms.

12 The most frequently endorsed initial symptoms among symptomatic patients were apathy

13 igher in children with longer delays between initial symptoms and arrival at the health facility (odd

14 ighly prevalent among cases reporting severe initial symptoms and, to a lesser extent, cases reportin

15 ed for clinical data including age at onset, initial symptoms, and best-corrected visual acuity.

16 ge, level of education, type and severity of initial symptoms are established predictors of recovery.

17 This study assessed the spectrum of initial symptoms at the onset of polymerase chain reacti

18 l records for age at onset, medical history, initial symptoms, best-corrected visual acuity (BCVA), o

19 patients for age at onset, medical history, initial symptoms, best-corrected visual acuity, ophthalm

20 ficantly to complex diseases, not by driving initial symptoms, but by altering repair mechanisms.

21 We reviewed the initial symptoms, clinical findings, surgical aspects, a

22 omposite indices integrating the most common initial symptoms for each genetic group.

23 tentially long-term consequences, even after initial symptoms have resolved.

24 that previous eye rubbing alone led to these initial symptoms, he was advised to stop rubbing and was

25 records were analyzed for 3 months following initial symptom identification to determine whether the

26 follow-up care documented within 3 months of initial symptom identification.

27 y moderate/severe symptom for >=2 days after initial symptom improvement.

28 Respiratory dysfunction, while not an initial symptom in many of these disorders, often drives

29 Behavioral or cognitive problems were the initial symptoms in 15 of 18 patients; less than half ex

30 objective was to evaluate the most frequent initial symptoms in patients with genetic FTD.

31 For most patients, the initial symptoms included falls, dysarthria, or clumsine

32 Initial symptoms included fever, cough, nasal congestion

33 Initial symptoms included rippling of lower limb muscles

34 3; 95% CI, 0.70-0.99; P = .008), more severe initial symptoms (moderate: OR, 0.99; 95% CI, 0.82-1.21;

35 Initial symptoms occurred at 59.3 (+/-12.3) years, and d

36 Especially when cytopenia is the initial symptom of a PID, the order and depth of diagnos

37 orted onset date was believed to reflect the initial symptoms of COVID-19, or insufficient evidence t

38 Initial symptoms of dyspnea, cough, weakness, and chest

39 Diagnosis is often delayed because the initial symptoms of fatigue and dyspnea on exertion are

40 neurologic diseases, although the causes and initial symptoms of individual diseases are distinct.

41 nscriptional response rapidly manifests into initial symptoms of leaf collapse within 2 h, although e

42 after a period of initial improvement after initial symptoms of the common cold, and often associate

43 6 years, but a quarter of patients developed initial symptoms only as adults.

44 symptom recurrence a median of 57 days after initial symptom onset (interquartile range: 47-76).

45 port patients after a minimum of 7 days from initial symptom onset and after sufficient time had pass

46 There is a wide range of age at initial symptom onset in amyotrophic lateral sclerosis d

47 bitors) in the 6 months prior to the time of initial symptom onset were considered exposed.

48 ature of OCD in adults, regardless of age at initial symptom onset.

49 resentation was more than twice as long from initial symptoms (p = 0.011) and nearly three times as l

50 ime for up to 20 yrs after the appearance of initial symptoms (p = 0.012), whereas phosphorylated alp

51 had received conventional immunotherapy for initial symptoms; patients were recruited from 21 hospit

52 a significant reduction in mean lag time to initial symptom perception and an increase in mean inten

53 Precipitating events, promoting factors, initial symptoms, physical and psychological comorbiditi

54 We evaluated the initial symptom presentation of patients with IBD in the

55 Eye soreness was the most common initial symptom (prevalence 69%), and the most frequent

56 ge pathway, emphasizing the critical role of initial symptom recognition, primary and dental care, pa

57 ne-third, especially in patients with severe initial symptoms, regardless of culture conversion.

58 Nyctalopia was the most common initial symptom, reported in 92.9% of patients (52/56).

59 s, or 5 percent), although in some cases the initial symptoms resembled those of acute myocardial inf

60 The combination of an elevated initial symptom score and failure to improve with self-m

61 ompared annual screening, with or without an initial symptom screen, for 10 years with 2 hypothetical

62 mpact of 2 hypothetical approaches following initial symptom screening: (i) 'moderate accuracy' testi

63 38; P = .04 and P < .001, respectively), but initial symptom severity did not (adjusted odds ratio, 1

64 FA values as stronger predictors of TSR than initial symptom severity.

65 Given its mild initial symptoms, T2DM is often diagnosed several years

66 Although we identified no initial symptoms that differentiated people diagnosed wi

67 ioterrorism agents of greatest concern cause initial symptoms that may be difficult to distinguish fr

68 Pertinent initial symptoms, time delay until diagnosis, and clinic

69 as paid to age, time to onset, implant type, initial symptoms, treatment, and survival.

70 The most common initial symptom was fever (59.3%).

71 ale patients differed in the degree to which initial symptoms were correlated with later function.

72 Initial symptoms were liver related in 26% of patients,

73 In this referred population, no initial symptoms were reported more frequently by patien

74 ess and loss of empathy were the most common initial symptoms, whereas during the disease course, pat